Invention Grant
- Patent Title: Engineered high-affinity human t cell receptors
-
Application No.: US15037485Application Date: 2014-11-21
-
Publication No.: US10344075B2Publication Date: 2019-07-09
- Inventor: Sheena N. Smith , Daniel T. Harris , David M. Kranz , Philip D. Greenberg , Thomas M. Schmitt
- Applicant: The Board of Trustees of the University of Illinois , Fred Hutchinson Cancer Research Center
- Applicant Address: US IL Urbana US WA Seattle
- Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS,FRED HUTCHINSON CANCER RESEARCH CENTER
- Current Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS,FRED HUTCHINSON CANCER RESEARCH CENTER
- Current Assignee Address: US IL Urbana US WA Seattle
- Agency: Cooley LLP
- International Application: PCT/US2014/066903 WO 20141121
- International Announcement: WO2015/077615 WO 20150528
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/735 ; C07K14/725 ; C07K14/47

Abstract:
T cell receptors (TCRs) that have specificity for the WT1 antigen are provided. The TCRs include higher affinity TCRs that were engineered through the generation of mutational libraries of TCRs in a single-chain format, followed by selection for improved stability and affinity on the surface of yeast (i.e. directed evolution). In embodiments, the TCRs can be used in soluble form for targeted delivery in vivo, or as genes introduced into T cells in an adoptive T cell setting.
Public/Granted literature
- US20160280756A1 ENGINEERED HIGH-AFFINITY HUMAN T CELL RECEPTORS Public/Granted day:2016-09-29
Information query
IPC分类: